These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18473710)

  • 1. Systemic retinoids in chemoprevention of non-melanoma skin cancer.
    Lens M; Medenica L
    Expert Opin Pharmacother; 2008 Jun; 9(8):1363-74. PubMed ID: 18473710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how.
    Bettoli V; Zauli S; Virgili A
    J Dermatolog Treat; 2013 Jun; 24(3):235-7. PubMed ID: 23148804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic retinoids: chemoprevention of skin cancer in transplant recipients.
    Hardin J; Mydlarski PR
    Skin Therapy Lett; 2010; 15(7):1-4. PubMed ID: 20700551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients.
    De Graaf YG; Euvrard S; Bouwes Bavinck JN
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):656-61. PubMed ID: 15061851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic retinoids in the management of ichthyoses and related skin types.
    Digiovanna JJ; Mauro T; Milstone LM; Schmuth M; Toro JR
    Dermatol Ther; 2013; 26(1):26-38. PubMed ID: 23384018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects.
    Otley CC; Stasko T; Tope WD; Lebwohl M
    Dermatol Surg; 2006 Apr; 32(4):562-8. PubMed ID: 16681667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.
    Herold M; Good AJ; Nielson CB; Longo MI
    Dermatol Surg; 2019 Dec; 45(12):1442-1449. PubMed ID: 31403546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic retinoids (acitretin, isotretinoin)].
    Berbis P
    Ann Dermatol Venereol; 2007 Dec; 134(12):935-41. PubMed ID: 18166914
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients.
    Marquez C; Bair SM; Smithberger E; Cherpelis BS; Glass LF
    J Drugs Dermatol; 2010 Jul; 9(7):753-8. PubMed ID: 20677528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians.
    Chroni E; Monastirli A; Tsambaos D
    Drug Saf; 2010 Jan; 33(1):25-34. PubMed ID: 20000864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.
    Chen K; Craig JC; Shumack S
    Br J Dermatol; 2005 Mar; 152(3):518-23. PubMed ID: 15787821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of tazarotene and acitretin in psoriasis.
    Heath MS; Sahni DR; Curry ZA; Feldman SR
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):919-927. PubMed ID: 30134735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid therapy for psoriasis.
    Yamauchi PS; Rizk D; Lowe NJ
    Dermatol Clin; 2004 Oct; 22(4):467-76, x. PubMed ID: 15450342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
    Kovach BT; Sams HH; Stasko T
    Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current use and future potential role of retinoids in dermatology.
    Orfanos CE; Zouboulis CC; Almond-Roesler B; Geilen CC
    Drugs; 1997 Mar; 53(3):358-88. PubMed ID: 9074840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin cancer chemoprevention with systemic retinoids: an adjunct in the management of selected high-risk patients.
    Campbell RM; DiGiovanna JJ
    Dermatol Ther; 2006; 19(5):306-14. PubMed ID: 17014486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Isotretinoin and Acitretin in Treatment of Frontal Fibrosing Alopecia: Retrospective Analysis of 54 Cases.
    Rakowska A; Gradzińska A; Olszewska M; Rudnicka L
    J Drugs Dermatol; 2017 Oct; 16(10):988-992. PubMed ID: 29036252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of retinoids in the prevention and treatment of skin cancer.
    Niles RM
    Expert Opin Pharmacother; 2002 Mar; 3(3):299-303. PubMed ID: 11866680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic retinoid therapy.
    DiGiovanna JJ
    Dermatol Clin; 2001 Jan; 19(1):161-7. PubMed ID: 11155580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An appraisal of oral retinoids in the treatment of pachyonychia congenita.
    Gruber R; Edlinger M; Kaspar RL; Hansen CD; Leachman S; Milstone LM; Smith FJ; Sidoroff A; Fritsch PO; Schmuth M
    J Am Acad Dermatol; 2012 Jun; 66(6):e193-9. PubMed ID: 21601946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.